Dr. Philip Bentley

Dr. Philip Bentley, a biochemist, boasts over 40 years of experience in drug metabolism and toxicology. After wrapping up his postdoctoral work at the University of Basel in Switzerland and the University of Mainz in Germany, he made a significant career move in 1979. He joined the Ciba - Geigy Central Toxicology Group, which later became Novartis. Notably, he held the position of Vice President of Toxicology/Pathology at Novartis (including Ciba - Geigy) for an impressive 35 years, a tenure that lasted until 2014.

Throughout his long - standing time at Novartis, Dr. Bentley was deeply involved in multiple critical areas. This included experimental toxicology, where he delved into the nitty - gritty of laboratory - based studies. He was also active in regulatory toxicology, ensuring that all activities complied with relevant regulations. Additionally, he played a key role in drug metabolism and disposition research. Since 1990, his contributions to preclinical drug development have been nothing short of remarkable. He has been part of over 40 new drug registrations, with his work covering a wide spectrum of therapeutic areas such as oncology, respiratory diseases, cardiovascular and metabolic diseases, infective diseases, and neuroscience.

Dr. Bentley retired from Novartis at the end of September 2014. Currently, he has transitioned into a preclinical safety consultant role at Toxicodynamix International LLC. He operates from bases in both Hendersonville, North Carolina, and Basel, Switzerland. Besides his consulting work, he has a long - standing passion for sharing knowledge. He has been actively lecturing in toxicology for over 30 years. At present, he not only organizes a course at the University of Basel but also contributes to the ECPM course at the same institution and the IMI SafeSciMet courses.

In terms of education, Dr. Bentley holds a BSc and a PhD in Biochemistry from the University of Hull, UK. He further enhanced his expertise by undertaking Post - Doctoral Fellowships at the University of Basel in Switzerland and at the University of Mainz in Germany.